Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination
Clinical trial NCT03576313 · COMPLETED
Trial details
- NCT number
- NCT03576313
- Sponsor
- London School of Hygiene and Tropical Medicine
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-11
- Primary completion
- 2019-12-31
- Enrollment
- 4939
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.